August 16-22, 2010
Vail Marriott Mountain Resort & Spa
Vail, Colorado
Jacqueline A. French, MD
Dr. Jacqueline French is a professor in the Department of Neurology NYU, in the
comprehensive Epilepsy Center, and Director of the Clinical Trials Consortium, an
academic group that has performed a number of early phase clinical trails in epilepsy,
and has developed new methodologies for epilepsy trials . She is the former Assistant
Dean for Clinical trials at the University of Pennsylvania. Dr. French trained in
Neurology at Mount Sinai Hospital in New York, and did her fellowship training in
EEG and epilepsy at Mount Sinai hospital and Yale University.
Dr. French has focused her research efforts on development of new therapeutics for
epilepsy. She has written many articles, editorials and chapters and has edited
two books on this subject, and is the co-director of a bi-annual symposium on trial
design and its implications. This symposium is an opportunity for representatives
from government (the FDA and the NIH), members of the academic community, and members
of the private research community to discuss drug development and determine new
strategies. This meeting has led to the implementation of new trial designs, as
well as new strategies for the approval of drugs for use in monotherapy. Dr. French
has also been active in creating practice parameters, serving on committees of the
American Academy of Neurology and the American Epilepsy Society and chairing several
practice parameter Task Forces. She is the 2005 recipient of the American Epilepsy
Society Service Award. She chaired an AAN/AES committee that produced two widely
quoted guidelines on the use of new antiepileptic drugs. She has also organized
a multicenter effort to prospectively evaluate outcome for patients initiated on
new antiepileptic drugs. She is the associate editor of Epilepsy Currents, the journal
of the American Epilepsy Society. She has served on the board of the American Epilepsy
Society and is the secretary of the American Society of Experimental Neurotherapeutics.
In addition, she is the head of the scientific advisory board of the Epilepsy Therapy
Development Project, a private group devoted to the development of new epilepsy
therapies.. She lectures in the US and internationally on topics related to antiepileptic
drug therapeutics. Currently, she serves as chair of the International League Against
Epilepsy North American Regional Commission.
APPLICATIONS DUE BY 3/26/2010
ACCEPTED PARTICIPANTS WILL RECEIVE FULL SCHOLARSHIPS FOR TUITION AND EXPENSES
|
Supported by the National Institute of Neurological Disorders and Stroke |
|